Miller Fisher syndrome: Toward a more comprehensive understanding

Chinese Medical Journal

Volumn 114, Issue 3, 2001, Pages 235-239

  Li, Haifeng ^a   Yuan, Jinmei ^b  

^a QINGDAO UNIVERSITY   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

GQ1b antibody; Guillain Barre syndrome; Miller fisher syndrome

Indexed keywords

CENTRAL NERVOUS SYSTEM; ELECTROPHYSIOLOGY; GUILLAIN BARRE SYNDROME; HUMAN; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW;

CENTRAL NERVOUS SYSTEM; ELECTROPHYSIOLOGY; HUMANS; MILLER FISHER SYNDROME;

EID: 0035296035     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Berlit P, Rakicky J. The Miller Fisher syndrome. Review of the literature. J Clin Neuroophthalmol 1992;12:57-63.
2. Benito-Leon J, Bravo J, Mateos F, et al. Miller Fisher syndrome in infancy. Childs Nerv Syst 1996;12:559-561.
3. Phillips MS, Stewart S, Anderson JR. Neuropathological findings in Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 1984;47: 492-495.
4. Barontini F, Di Lollo S, Maurri S, et al. Localization of the pathological process in Miller Fisher syndrome. Ital J Neurol Sci 1992;13:221-225.
5. Urushitani M, Udaka F, Kameyama M. Miller Fisher-Guillain-Barre overlap syndrome with enhancing lesions in the spinocerebellar tracts. J Neurol Neurosurg Psychiatry 1995;58:241-243.
6. Ouhabi H, Bourazza A, Rouimi A, et al. Bilateral optic neuritis and ponto-mesencephalic involvement shown by MRI in Miller-Fisher syndrome. Rev Neurol (Paris) 1998;154:780-782.
7. Tanaka H, Yuki N, Hirata K, et al. Trochlear nerve enhancement on three-dimensional magnetic resonance imaging in Fisher syndrome. Am J Ophthalmol 1998;126:322-324.
8. Fross RD, Daube JR. Neuropathy in the Miller Fisher syndrome: clinical and electrophysiologic findings. Neurology 1987;37:1493-1498.
9. Wong V. A neurophysiological study in children with Miller Fisher syndrome and Guillain-Barre syndrome. Brain Dev 1997;19:197-204.
10. Uncini A, Lugaresi A. Fisher syndrome with tetraparesis and antibody to GQ1b: evidence for motor nerve terminal block. Muscle Nerve 1999;22:640-644.
11. Chida K, Nomura H, Konno H, et al. Recurrent Miller Fisher syndrome: clinical and laboratory features and HLA antigens. J Neurol Sci 1999;165:139-143.
12. O'Leary CP, Veitch J, Durward WF, et al. Acute oropharyngeal palsy is associated with antibody to GQIb and GT1a gangliosides. J Neurol Neurosurg Psychiatry 1996;61:649-651.
13. Ter Bruggen JP, van der Meche FG, de Jager AE, et al. Ophthalmoplegic and lower cranial nerve variants merge into each other and into classical Guillain-Barre syndrome. Muscle Nerve 1998;21:239-242.
14. Suzuki T, Chiba A, Kusunoki S, et al. Anti-GQ1b ganglioside antibody and ophthalmoplegia of undetermined cause. Br J Ophthalmol 1998;82:916-918.
15. Kusunoki S, Chiba A, Kanazawa I. Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia. Muscle Nerve 1999;22:1071-1074.
16. O'Leary CP, Willison HJ. Autoimmune ataxic neuropathies (sensory ganglionopathies) . Curr Opin Neurol 1997;10:366-370.
17. Willison HJ, O'Hanlon G, Paterson G, et al. Mechanisms of action of anti-GM1 and anti-GQ1b ganglioside antibody in Guillain-Barre syndrome. J Infect Dis 1997;176 (Suppl 2):S144-S149.
18. Toshniwal P. Demyelinating oplic neuropathy with Miller-Fisher syndrome. The case for overlap syndromes with central and peripheral demyelination. J Neurol 1987;234:353-358.
19. Chiba A, Kusunoki S, Obala H, et al. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barre syndrome: clinical and immunohistochemical studies. Neurology 1993;43:1911-1917.
20. Ohtsuka K, Nakamura Y, Tagawa Y, et al. Immunoadsorption therapy for Fisher syndrome associated with IgG anti-GQ1b antibody. Am J Ophthalmol 1998;125:403-406.
21. Mizoguchi K. Anli-GQ1b IgG antibody activities related to the severity of Miller Fisher syndrome. Neurol Res 1998;20:617-624.
22. Chiba A, Kusunoki S, Obata H, et al. Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of MFS. Brain Res 1997;745:32-36.
23. Schwerer B, Neisser A, Bernheimer H. Distinct immunoglobulin class and immunoglobulin G subclass patterns against ganglioside GQ1b in Miller Fisher syndrome following different types of infection. Infect Immun 1999;67:2414-2420.
24. Yuki N, Takahashi M, Tagawa Y, et al. Association of Campylobacter jejuni serotype with anti-ganglioside antibody in Guillain-Barre syndrome and Fisher s syndrome. Ann Neurol 1997;42:28-33.
25. Ohtsuka K, Nakamura Y, Hashimoto M, et al. Fisher syndrome associated with IgG anti-GQ1b antibody following infection by a specific serotype of Campylobacter jejuni. Ophthalmology 1998; 105:1281-1285.
26. Yuki N, Taki T, Takahashi M, et al. Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher' s syndrome. Ann Neurol 1994; 36:791-793.
27. Roberts M, Willison H, Vincent A, et al. Serum factor in Miller-Fisher variant of Guillain-Barre syndrome and neurotransmitter release. Lancet 1994;343:454-455.
28. Buchwald B, Weishaupt A, Toyka KV, et al. Pre- and postsynaptic blockade of neuromuscular transmission by Miller-Fisher syndrome IgG at mouse motor nerve terminals. Eur J Neurosci 1998;10:281-290.
29. Plomp JJ, Molenaar PC, O'Hanlon GM, et al. Miller Fisher anti-GQ1b antibody: alpha-latrotoxin-like effects on motor end plates. Ann Neurol 1999;45:189-199.
30. Carpo M, Pedotti R, Allaria S, et al. Clinical presentation and outcome of GBS and related syndromes in relation to antiganglioside antibody. J Neurol Sci 1999;168:78-84.
31. Irvine AT, Tibbles J. Treatment of Fisher's variant of Guillain-Barre syndrome by exchange transfusion. Can J Neurol Sci 1981; 8:49-50.
32. Arakawa Y, Yoshimura M, Kobayashi S, et al. The use of intravenous immunoglobulin in Miller Fisher syndrome. Brain Dev 1993;15:231-233.
33. Zifko U, Drlicek M, Senantka G, et al. High dose immunoglobulin therapy is effective in the Miller Fisher syndrome. J Neurol 1994;241:178-179.
34. Ohtsuka K, Nakamura Y, Tagawa Y, et al. Immunoadsorption therapy for Fisher syndrome associated with IgG anti-GQ1b antibody. Am J Ophthalmol 1998;125:403-406.
35. Yeh JH, Chen WH, Chen JR, et al. Miller Fisher syndrome with central involvement: successful treatment with plasmapheresis. Ther Apher 1999;3:69-71.